AK & SCC Flashcards
squamous cell carcinoma (SCC) most commonly occurs:
in who?
Where?
WHITE/FAIR SKIN people
SUN-EXPOSED AREAS (head, neck, forearms, dorsal hands)
SCC vs BCC mortality
SCC has INCREASED mortality, mostly due to high rate of metastasis
SCC etiology
cell of origin: KERATINOCYTE
cumulative UV exposure->genetic alterations accumulate, provide selective growth advantage
SCC in NON sun-exposed areas may be due to chemical carcinogens (eg. arsenic)
SCC morphology
varies:
- papule, plaque or nodule
- pink, red or skin colored
- scale
- Exophytic (grows outward)
- Indurated (lesion feels thick, firm)
- cutaneous horm
FRIABLE: bleed w/minimal traum then crust
(U) asymptomatic, may be pruritic
SCC in situ
aka Bowen’s dz
circumscribed pink-to-red patch
or
thin plaque w/scaly or rough surface
keratinocyte atypia is confined to epidermis, DOES NOT invade past dermal-epidural junction
Shave biopsy use
diagnosis
Surgical excision use
treatment of choice for SCC in situ
specimen must be sent to pathology to document clear margins (complete excision)
Liquid nitrogen cryotherapy use
to tx pre-cancerous actinic keratosis
“Invasive squamous cell carcinoma” means
there are SCC cells IN THE DERMIS
unrelated to metastatic potential
SCC in situ means
there is NO DERMAL INVOLVEMENT
“Atypical squamous proliferation” means
often used when biopsy is too superficial
if dermis cannot be seen in the biopsy, invasive SCC cannot be excluded
SCC treatment options:
surgical (invasive, in-situ)
- surgical excision (invasive SCC):
- wide local excision, Mohs -micrographic surgery - curette & desiccation (in situ SCC)
SCC non-surgical tx options
radiation therapy for poor surgical candidates
5-fluorouracil cream, imiquimod cream, photodynamic therapy-(U) used for in situ SCC when excision is suboptimal choice
SCC: rates of mets
SCC in sun exposed area=5% rate of mets to regional lymph nodes
higher rates of metastasis if:
- large (diameter>2cm), deep (>4mm) and recurrent tumors
- tumor involvement of bone, muscle & nerve
- location on scalp ears nose & lips
- tumor arising in scars chronic ulcers, burns, sinus tracts or on genitalia
- Immunosuppressed patients
- tumors caused by arsenic ingesion
SCC patient follow up
surveillance for the early recognition & management of:
- tx-related complications
- local or regional recurrences
- development of new skin cancers
patients with a hx of SCC should have close follow-up
patients are often seen every 6 to 12 months